Matches in Wikidata for { <http://www.wikidata.org/entity/Q89154077> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q89154077 description "clinical trial" @default.
- Q89154077 description "ensayu clínicu" @default.
- Q89154077 description "klinisch onderzoek" @default.
- Q89154077 description "клінічне випробування" @default.
- Q89154077 description "կլինիկական փորձարկում" @default.
- Q89154077 name "Phase III Randomized Clinical Trial Comparing Post-Transplant Cyclophosphamide (PTCy) to Standard Care (SoC) for Acute Leukemia" @default.
- Q89154077 name "Phase III Randomized Clinical Trial Comparing Post-Transplant Cyclophosphamide (PTCy) to Standard Care (SoC) for Acute Leukemia" @default.
- Q89154077 type Item @default.
- Q89154077 label "Phase III Randomized Clinical Trial Comparing Post-Transplant Cyclophosphamide (PTCy) to Standard Care (SoC) for Acute Leukemia" @default.
- Q89154077 label "Phase III Randomized Clinical Trial Comparing Post-Transplant Cyclophosphamide (PTCy) to Standard Care (SoC) for Acute Leukemia" @default.
- Q89154077 prefLabel "Phase III Randomized Clinical Trial Comparing Post-Transplant Cyclophosphamide (PTCy) to Standard Care (SoC) for Acute Leukemia" @default.
- Q89154077 prefLabel "Phase III Randomized Clinical Trial Comparing Post-Transplant Cyclophosphamide (PTCy) to Standard Care (SoC) for Acute Leukemia" @default.
- Q89154077 P1050 Q89154077-C9FDAE3F-88F5-4247-8E7F-84BBE13F2475 @default.
- Q89154077 P1132 Q89154077-4AF7F8A5-9B1D-4DFD-9A9E-20DF6DB92F75 @default.
- Q89154077 P1476 Q89154077-F9C85A91-0338-4B82-9580-1813115F0AD5 @default.
- Q89154077 P17 Q89154077-1CE34519-C6CD-4D59-9A21-E9D1A57F49C0 @default.
- Q89154077 P2899 Q89154077-86BD452F-5516-44FF-8299-B8B107D1F8EC @default.
- Q89154077 P3098 Q89154077-71FBEABC-E6E0-42AC-811A-423A0C4587C1 @default.
- Q89154077 P31 Q89154077-B94D19B4-7AE2-42E8-BF8F-585C6F220183 @default.
- Q89154077 P4135 Q89154077-EFDE11DC-0200-41E4-8D11-56C856C890A5 @default.
- Q89154077 P4844 Q89154077-5C06F454-9743-4CCD-BA2D-A567BABF2BCA @default.
- Q89154077 P4844 Q89154077-985F735C-D283-4897-9CF9-E3DF96A3DC9D @default.
- Q89154077 P4844 Q89154077-E303CAB9-0C14-4E49-A048-6EB206490B9A @default.
- Q89154077 P580 Q89154077-4BB6842A-CF0F-4A20-AABD-F40A22E99A3B @default.
- Q89154077 P582 Q89154077-4BA01BCE-AABB-4264-BFD6-EA3E974A55A5 @default.
- Q89154077 P6099 Q89154077-4F11ACD4-C7E5-4DA3-90C4-624B88EDD53C @default.
- Q89154077 P8363 Q89154077-D9C4CD4D-EDFE-468D-98EB-9DAD7716AEF9 @default.
- Q89154077 P1050 Q29496 @default.
- Q89154077 P1132 "+264" @default.
- Q89154077 P1476 "Phase III Randomized Clinical Trial Comparing Post-Transplant Cyclophosphamide With Calcineurin Inhibitors as GVHD Prophylaxis to Standard Care of Methotrexate and Calcineurin Inhibitors for Acute Leukemia Incorporating Patient Pharmacogenomics Profiling (PMAT)" @default.
- Q89154077 P17 Q851 @default.
- Q89154077 P2899 "+14" @default.
- Q89154077 P3098 "NCT04314219" @default.
- Q89154077 P31 Q30612 @default.
- Q89154077 P4135 "+65" @default.
- Q89154077 P4844 Q408524 @default.
- Q89154077 P4844 Q422232 @default.
- Q89154077 P4844 Q50430479 @default.
- Q89154077 P580 "2020-02-23T00:00:00Z" @default.
- Q89154077 P582 "2024-02-23T00:00:00Z" @default.
- Q89154077 P6099 Q42824827 @default.
- Q89154077 P8363 Q78089383 @default.